India, May 1 -- India's bioeconomy has grown from approximately $10 billion in 2014 to over $195 billion in 2025, contributing nearly 4.8 per cent to GDP. Industrial biotechnology now accounts for 46 per cent of the bioeconomy, followed by biopharma (33 per cent), bioservices (13 per cent) and bioagri (8 per cent).

There is a surge in biotechnology startups, rising from about 460 to more than 11,850 over the same period. Economic progress has been driven mainly by contract development and manufacturing, with core technologies and production platforms still largely imported. Indigenous, Research and Development (R&D)-led product innovation remains limited, and short-term capital-based startups often prioritise near-term returns over the l...